CV Lattes
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Coordenadoria de Serviços de Saúde (CSS). Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira (ICESP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Medicina from Universidade de São Paulo (1995) and doctorate at Urologia from Faculdade de Medicina da Usp (2010). He is currently pesquisador científico at Faculdade de Medicina da Universidade de São Paulo and médico assistente at Instituto do Câncer do Estado de São Paulo. Has experience in Medicine, focusing on Urological Surgery, acting on the following subjects: câncer de próstata, psa, biópsia, prognosis and prostate cancer. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Introduction: The penile cancer, although rare in Western countries, accounts for up to 20% of male cancers in developing countries. The main penile cancer prognostic factors are the pathological stage and tumor grade, although they are useful in daily practice, these factors have performance below desired. The surgical treatment of localized tumor with penectomy and inguinal lymphadenect…
Prostate cancer is the most common non cutaneous tumor and the second cause of death by cancer in western countries in males. Radical prostatectomy and radiotherapy are the main options of treatment with curative intention, but up to a quarter of patients have biochemical recurrence during the follow up. The classic prognostic factors can estimate tumor aggressiveness and chance of tum…
Prostate cancer is the most common malignant tumor in men and the second leading cause of cancer death in Western countries. With the advent of prostate specific antigen (PSA) and the adoption of screening programs there was clearly an increased detection of the disease at an earlier stage. Tumor diagnosis is established by prostate biopsy that is usually guided by transrectal ultrasonogr…
Prostate cancer is the most common noncutaneous tumor and the second cause of death by cancer in western countries in males. Radical prostatectomy and radiotherapy are the main options of treatment with curative intention, but up to a quarter of patients have a biochemical recurrence during the follow-up. The classic prognostic factors can estimate tumor aggressiveness and the chance of t…
| 3 / 2 | Completed research grants |
| 3 / 3 | Completed scholarships in Brazil |
| 6 / 5 | All research grants and scholarships |
| Associated processes | |